ADAM10 is the constitutive functional sheddase of CD44 in human melanoma cells

Journal of Investigative Dermatology

Volumn 129, Issue 6, 2009, Pages 1471-1482

  Anderegg, Ulf ^a,d   Eichenberg, Thea ^a   Parthaune, Tanja ^a   Haiduk, Christian ^a   Saalbach, Anja ^a   Milkova, Linda ^a   Ludwig, Andreas ^b   Grosche, Jens ^a   Averbeck, Marco ^a   Gebhardt, Carl ^a   Voelcker, Verena ^a   Sleeman, Jonathan P ^c   Simon, Jan C ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b RWTH AACHEN UNIVERSITY   (Germany)

^c UNIVERSITY OF HEIDELBERG   (Germany)

^d Max Burger Forschungszentrum   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; ADAM PROTEIN; ADAM10 PROTEIN; CELL SURFACE RECEPTOR; HERMES ANTIGEN; HYALURONIC ACID; MATRIX METALLOPROTEINASE 14; PROTEINASE; SMALL INTERFERING RNA; TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CELL FUNCTION; CELL PROLIFERATION; CELL SURFACE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MELANOMA CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION;

ADAM PROTEINS; AMYLOID PRECURSOR PROTEIN SECRETASES; ANTIGENS, CD44; CELL LINE, TUMOR; CELL MEMBRANE; CELL PROLIFERATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; HUMANS; IMMUNOHISTOCHEMISTRY; MATRIX METALLOPROTEINASE 14; MELANOMA; MEMBRANE PROTEINS; MICROSCOPY, CONFOCAL; MODELS, BIOLOGICAL; RNA, SMALL INTERFERING;

EID: 66149150300     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2008.323     Document Type: Article

References (49)

1. Ahrens T, Assmann V, Fieber C, Termeer C, Herrlich P, Hofmann M et al. (2001a) CD44 is the principal mediator of hyaluronic-acid-induced melanoma cell proliferation. J Invest Dermatol 116:93-101
2. Ahrens T, Sleeman JP, Schempp CM, Howells N, Hofmann M, Ponta H et al. (2001b) Soluble CD44 inhibits melanoma tumor growth by blocking cell surface CD44 binding to hyaluronic acid. Oncogene 20:3399-408
3. Angelo PF, Lima AR, Alves FM, Blaber SI, Scarisbrick IA, Blaber M et al. (2006) Substrate specificity of human kallikrein 6: salt and glycosaminoglycan activation effects. J Biol Chem 281:3116-26
4. Aruffo A, Stamenkovic I, Melnick M, Underhill CB, Seed B (1990) CD44 is the principal cell surface receptor for hyaluronate. Cell 61:1303-13
5. Bennett KL, Jackson DG, Simon JC, Tanczos E, Peach R, Modrell B et al. (1995) CD44 isoforms containing exon V3 are responsible for the presentation of heparin-binding growth factor. J Cell Biol 128:687-98
6. Budagian V, Bulanova E, Orinska Z, Duitman E, Brandt K, Ludwig A et al. (2005) Soluble Axl is generated by ADAM10-dependent cleavage and associates with Gas6 in mouse serum. Mol Cell Biol 25:9324-39
7. Dietrich A, Tanczos E, Vanscheidt W, Schopf E, Simon JC (1997) High CD44 surface expression on primary tumours of malignant melanoma correlates with increased metastatic risk and reduced survival. Eur J Cancer 33:926-30
8. Gasbarri A, Del PF, Girnita L, Martegani MP, Natali PG, Bartolazzi A (2003) CD44s adhesive function spontaneous and PMA-inducible CD44 cleavage are regulated at post-translational level in cells of melanocytic lineage. Melanoma Res 13:325-37
9. Goebeler M, Kaufmann D, Brocker EB, Klein CE (1996) Migration of highly aggressive melanoma cells on hyaluronic acid is associated with functional changes, increased turnover and shedding of CD44 receptors. J Cell Sci 109(Pt 7):1957-64
10. Hoashi T, Kadono T, Kikuchi K, Etoh T, Tamaki K (2001) Differential growth regulation in human melanoma cell lines by TIMP-1 and TIMP-2. Biochem Biophys Res Commun 288:371-9
11. Hundhausen C, Misztela D, Berkhout TA, Broadway N, Saftig P, Reiss K et al. (2003) The disintegrin-like metalloproteinase ADAM10 is involved in constitutive cleavage of CX3CL1 (fractalkine) and regulates CX3CL1-mediated cell-cell adhesion. Blood 102:1186-95
12. Janes PW, Saha N, Barton WA, Kolev MV, Wimmer-Kleikamp SH, Nievergall E et al. (2005) Adam meets Eph: an ADAM substrate recognition module acts as a molecular switch for ephrin cleavage in trans. Cell 123:291-304
13. Kajita M, Itoh Y, Chiba T, Mori H, Okada A, Kinoh H et al. (2001) Membrane-type 1 matrix metalloproteinase cleaves CD44 and promotes cell migration. J Cell Biol 153:893-904
14. Klucky B, Mueller R, Vogt I, Teurich S, Hartenstein B, Breuhahn K et al. (2007) Kallikrein 6 induces E-cadherin shedding and promotes cell proliferation, migration, and invasion. Cancer Res 67:8198-206
15. Kooy AJ, Tank B, de Jong AA, Vuzevski VD, van der Kwast TH, van JT (1999) Expression of E-cadherin, alpha- & beta-catenin, and CD44V6 and the subcellular localization of E-cadherin and CD44V6 in normal epidermis and basal cell carcinoma. Hum Pathol 30:1328-35
16. Li L, Heldin CH, Heldin P (2006) Inhibition of platelet-derived growth factor-BB-induced receptor activation and fibroblast migration by hyaluronan activation of CD44. J Biol Chem 281:26512-9
17. Lockshin A, Giovanella BC, De Ipolyi PD, Williams LJ Jr, Mendoza JT, Yim SO et al. (1985) Exceptional lethality for nude mice of cells derived from a primary human melanoma. Cancer Res 45:345-50
18. Ludwig A, Hundhausen C, Lambert MH, Broadway N, Andrews RC, Bickett DM et al. (2005) Metalloproteinase inhibitors for the disintegrin-like metalloproteinases ADAM10 and ADAM17 that differentially block constitutive and phorbol ester-inducible shedding of cell surface molecules. Comb Chem High Throughput Screen 8:161-71
19. Maretzky T, Reiss K, Ludwig A, Buchholz J, Scholz F, Proksch E et al. (2005) ADAM10 mediates E-cadherin shedding and regulates epithelial cell-cell adhesion, migration, and beta-catenin translocation. Proc Natl Acad Sci USA 102:9182-7
20. Mayer C, Maaser K, Daryab N, Zanker KS, Brocker EB, Friedl P (2004) Release of cell fragments by invading melanoma cells. Eur J Cell Biol 83:709-15
21. Mochizuki S, Okada Y (2007) ADAMs in cancer cell proliferation and progression. Cancer Sci 98:621-8
22. Molica S, Vitelli G, Levato D, Giannarelli D, Gandolfo GM (2001) Elevated serum levels of soluble CD44 can identify a subgroup of patients with early B-cell chronic lymphocytic leukemia who are at high risk of disease progression. Cancer 92:713-9
23. Mori H, Tomari T, Koshikawa N, Kajita M, Itoh Y, Sato H et al. (2002) CD44 directs membrane-type 1 matrix metalloproteinase to lamellipodia by associating with its hemopexin-like domain. EMBO J 21:3949-59
24. Morrison H, Sherman LS, Legg J, Banine F, Isacke C, Haipek CA et al. (2001) The NF2 tumor suppressor gene product, merlin, mediates contact inhibition of growth through interactions with CD44. Genes Dev 15:968-80
25. Murai T, Miyazaki Y, Nishinakamura H, Sugahara KN, Miyauchi T, Sako Y et al. (2004) Engagement of CD44 promotes Rac activation and CD44 cleavage during tumor cell migration. J Biol Chem 279:4541-50
26. Nagano O, Murakami D, Hartmann D, De SB, Saftig P, Iwatsubo T et al. (2004) Cell-matrix interaction via CD44 is independently regulated by different metalloproteinases activated in response to extracellular Ca(2+) influx and PKC activation. J Cell Biol 165:893-902
27. Nagano O, Saya H (2004) Mechanism and biological significance of CD44 cleavage. Cancer Sci 95:930-5
28. Nakamura H, Suenaga N, Taniwaki K, Matsuki H, Yonezawa K, Fujii M et al. (2004) Constitutive and induced CD44 shedding by ADAM-like proteases and membrane-type 1 matrix metalloproteinase. Cancer Res 64:876-82
29. Naor D, Sionov RV, Ish-Shalom D (1997) CD44: structure, function, and association with the malignant process. Adv Cancer Res 71:241-319
30. Niitsu N, Iijima K (2002) High serum soluble CD44 is correlated with a poor outcome of aggressive non-Hodgkin's lymphoma. Leuk Res 26:241-8
31. Okamoto I, Kawano Y, Tsuiki H, Sasaki J, Nakao M, Matsumoto M et al. (1999) CD44 cleavage induced by a membrane-associated metallopro-tease plays a critical role in tumor cell migration. Oncogene 18: 1435-46
32. Ponta H, Sherman L, Herrlich PA (2003) CD44: from adhesion molecules to signalling regulators. Nat Rev Mol Cell Biol 4:33-45
33. Reiss K, Ludwig A, Saftig P (2006) Breaking up the tie: disintegrin-like metalloproteinases as regulators of cell migration in inflammation and invasion. Pharmacol Ther 111:985-1006
34. Scacheri PC, Rozenblatt-Rosen O, Caplen NJ, Wolfsberg TG, Umayam L, Lee JC et al. (2004) Short interfering RNAs can induce unexpected and divergent changes in the levels of untargeted proteins in mammalian cells. Proc Natl Acad Sci USA 101:1892-7
35. Sheen-Chen SM, Chen WJ, Eng HL, Sheen CC, Chou FF, Cheng YF (1999) Evaluation of the prognostic value of serum soluble CD 44 in patients with breast cancer. Cancer Invest 17:581-5
36. Shi M, Dennis K, Peschon JJ, Chandrasekaran R, Mikecz K (2001) Antibody-induced shedding of CD44 from adherent cells is linked to the assembly of the cytoskeleton. J Immunol 167:123-31
37. Sledz CA, Holko M, de Veer MJ, Silverman RH, Williams BR (2003) Activation of the interferon system by short-interfering RNAs. Nat Cell Biol 5:834-9
38. Stamenkovic I, Aruffo A, Amiot M, Seed B (1991) The hematopoietic and epithelial forms of CD44 are distinct polypeptides with different adhesion potentials for hyaluronate-bearing cells. EMBO J 10:343-8
39. Stickeler E, Vogl FD, Denkinger T, Mobus VJ, Kreienberg R, Runnebaum IB (2000) Soluble CD44 splice variants and pelvic lymph node metastasis in ovarian cancer patients. Int J Mol Med 6:595-601
40. Stoeck A, Keller S, Riedle S, Sanderson MP, Runz S, Le NF et al. (2006) A role for exosomes in the constitutive and stimulus-induced ectodomain cleavage of L1 and CD44. Biochem J 393:609-18
41. Ueda J, Kajita M, Suenaga N, Fujii K, Seiki M (2003) Sequence-specific silencing of MT1-MMP expression suppresses tumor cell migration and invasion: importance of MT1-MMP as a therapeutic target for invasive tumors. Oncogene 22:8716-22
42. van Muijen GN, Danen EH, de Vries TJ, Quax PH, Verheijen JH, Ruiter DJ (1995) Properties of metastasizing and nonmetastasizing human melanoma cells. Recent Results Cancer Res 139:105-22
43. Wild-Bode C, Fellerer K, Kugler J, Haass C, Capell A (2006) A basolateral sorting signal directs ADAM10 to adherens junctions and is required for its function in cell migration. J Biol Chem 281:23824-9
44. Wobus M, Rangwala R, Sheyn I, Hennigan R, Coila B, Lower EE et al. (2002) CD44 associates with EGFR and erbB2 in metastasizing mammary carcinoma cells. Appl Immunohistochem Mol Morphol 10:34-9
45. Yamane N, Tsujitani S, Makino M, Maeta M, Kaibara N (1999) Soluble CD44 variant 6 as a prognostic indicator in patients with colorectal cancer. Oncology 56:232-8
46. Yasasever V, Tas F, Duranyildiz D, Camlica H, Kurul S, Dalay N (2000) Serum levels of the soluble adhesion molecules in patients with malignant melanoma. Pathol Oncol Res 6:42-5
47. Yu Q, Stamenkovic I (1999) Localization of matrix metalloproteinase 9 to the cell surface provides a mechanism for CD44-mediated tumor invasion. Genes Dev 13:35-48
48. Yu WH, Woessner JF Jr, McNeish JD, Stamenkovic I (2002) CD44 anchors the assembly of matrilysin/MMP-7 with heparin-binding epidermal growth factor precursor and ErbB4 and regulates female reproductive organ remodeling. Genes Dev 16:307-23
49. Zigrino P, Mauch C, Fox JW, Nischt R (2005) Adam-9 expression and regulation in human skin melanoma and melanoma cell lines. Int J Cancer 116:853-9